The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis.
Roberts ZJ; Goutagny N; Perera PY; Kato H; Kumar H; Kawai T; Akira S; Savan R; van Echo D; Fitzgerald KA; Young HA; Ching LM; Vogel SN; The Journal Of Experimental Medicine, 2007, vol. 204, issue 7, p 1559, ISSN 00221007. ISBN 00221007.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef